Excluding impairment of RM9.9m, 3Q18 core earnings fell -47.5% yoy to RM5.9m as EBITDA margin narrowed despite higher progressed billings +10.8%. On qoq basis, core earnings jumped 3.75x mainly on deferred tax credit of RM3.3m during the period. At pretax level, earnings improved 50% qoq.
9M18 core EBITDA and PBT were broadly inline with ours and consensus estimates at 76.4% and 71.4%; this was mainly due to the surge in EBITDA margin as progress billing trailed our 2018F revenues at only 51.9%. We believe the improved margin is not sustainable as management cited tough operating landscape ahead. We believe regulatory cost could increase, possibly from increase in minimum wage.
For FY18F, we revised revenue by -30.4% to reflect the slower-thanexpected progress billing. Despite outstanding orderbook at RM820m, we take a more conservative view on its earnings outlook; we cut 2019F and 2020F PBT by -15.7% and -3.7% respectively on the back of lower margins assumed to reflect our expectations of higher input costs.
SELL with revised TP of RM0.095 after pegging 8.5x PE (from 10x) to its FY19F EPS; this is a 20% discount to sector average to reflect its tight cashflow and strained balance sheet which relies on bank overdraft for working capital.
Source: BIMB Securities Research - 3 Dec 2018
Chart | Stock Name | Last | Change | Volume |
---|
Created by kltrader | Nov 12, 2024
Created by kltrader | Nov 11, 2024
Created by kltrader | Nov 11, 2024
Created by kltrader | Nov 11, 2024